TESTOSTERONE CYPIONATE

TESTOSTERONE CYPIONATE was reported 9049 times

TESTOSTERONE CYPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT GEL FORMATION 36 0.2951
1 CORONARY BYPASS THROMBOSIS 13 0.2766
2 PRODUCT DEPOSIT 325 0.2085
3 PRODUCT WITH QUALITY ISSUE ADMINISTERED 63 0.1413
4 CARDIAC VALVE FIBROELASTOMA 5 0.1282
5 METAPLASIA 34 0.0720
6 PERFORMANCE ENHANCING PRODUCT USE 5 0.0505
7 POLYCYTHAEMIA 82 0.0397
8 TESTICULAR FAILURE 5 0.0365
9 LIQUID PRODUCT PHYSICAL ISSUE 255 0.0349
10 BLOOD TESTOSTERONE INCREASED 73 0.0339
11 SUSPECTED PRODUCT TAMPERING 19 0.0339
12 SECONDARY HYPOGONADISM 11 0.0333
13 EXPOSURE TO UNSPECIFIED AGENT 6 0.0306
14 HYPOGONADISM MALE 7 0.0302
15 ISCHAEMIA 127 0.0276
16 PRODUCT CLOSURE ISSUE 15 0.0269
17 OESTRADIOL INCREASED 7 0.0233
18 POOR QUALITY PRODUCT ADMINISTERED 244 0.0231
19 IDIOPATHIC INTRACRANIAL HYPERTENSION 47 0.0209
20 BLOOD TESTOSTERONE ABNORMAL 23 0.0208
21 MULTIPLE USE OF SINGLE-USE PRODUCT 115 0.0205
22 INFARCTION 133 0.0194
23 BLOOD TESTOSTERONE DECREASED 125 0.0183
24 HAEMATOCRIT INCREASED 40 0.0175
25 HEPATIC ADENOMA 9 0.0174
26 BLOOD OESTROGEN INCREASED 10 0.0170
27 MALABSORPTION FROM INJECTION SITE 5 0.0161
28 HYPOGONADISM 16 0.0158
29 PRODUCT ADMINISTERED BY WRONG PERSON 6 0.0157
30 POLYCYTHAEMIA VERA 12 0.0147
31 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 5 0.0139
32 MUSCLE MASS 6 0.0133
33 SUSPECTED PRODUCT CONTAMINATION 12 0.0118
34 TESTICULAR ATROPHY 10 0.0115
35 ANDROGEN DEFICIENCY 4 0.0114
36 MARITAL PROBLEM 6 0.0111
37 CARDIAC VENTRICULAR THROMBOSIS 14 0.0108
38 PRODUCT CONTAMINATION PHYSICAL 26 0.0102
39 BLOOD VISCOSITY INCREASED 6 0.0099
40 QUALITY OF LIFE DECREASED 129 0.0096
41 DEEP VEIN THROMBOSIS 622 0.0096
42 PRODUCT TAMPERING 17 0.0095
43 INSULIN-LIKE GROWTH FACTOR DECREASED 5 0.0095
44 CARDIOVASCULAR DISORDER 225 0.0089
45 POOR QUALITY DRUG ADMINISTERED 57 0.0088
46 CORONARY ARTERY THROMBOSIS 16 0.0079
47 THROMBOPHLEBITIS SUPERFICIAL 24 0.0079
48 ENDOMETRIAL ADENOCARCINOMA 5 0.0079
49 PRE-EXISTING CONDITION IMPROVED 49 0.0078
50 ACUTE MYOCARDIAL INFARCTION 231 0.0078
51 PROSTATE INFECTION 7 0.0073
52 ESSENTIAL TREMOR 8 0.0072
53 PROSTATIC DISORDER 39 0.0071
54 PHYSICAL DISABILITY 31 0.0070
55 TESTICULAR DISORDER 7 0.0070
56 RED BLOOD CELL COUNT INCREASED 19 0.0069
57 BONE DEMINERALISATION 7 0.0066
58 HAEMOGLOBIN INCREASED 30 0.0066
59 INJECTION SITE INFECTION 21 0.0064
60 PRODUCT ADMINISTRATION INTERRUPTED 50 0.0064
61 PULMONARY INFARCTION 15 0.0063
62 INSULIN-LIKE GROWTH FACTOR INCREASED 9 0.0063
63 HYPERCOAGULATION 12 0.0063
64 RECALLED PRODUCT ADMINISTERED 60 0.0063
65 PRODUCT COLOUR ISSUE 32 0.0062
66 ECONOMIC PROBLEM 92 0.0061
67 DILATED CARDIOMYOPATHY 6 0.0059
68 PULMONARY EMBOLISM 558 0.0059
69 PERIPHERAL ARTERY THROMBOSIS 8 0.0057
70 HEART INJURY 14 0.0056
71 EMBOLISM VENOUS 17 0.0056
72 MYOCARDIAL INFARCTION 949 0.0054
73 PRODUCT CONTAMINATION 19 0.0053
74 PARTNER STRESS 5 0.0052
75 PRODUCT CONTAINER SEAL ISSUE 9 0.0052
76 THERAPEUTIC PRODUCT EFFECT INCREASED 6 0.0052
77 ESSENTIAL HYPERTENSION 9 0.0049
78 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 6 0.0048
79 HYPOTHALAMO-PITUITARY DISORDER 7 0.0048
80 CORONARY ARTERY DISEASE 141 0.0047
81 SOCIAL PROBLEM 19 0.0046
82 AORTIC THROMBOSIS 5 0.0043
83 THROMBOSIS 347 0.0043
84 EPIDIDYMITIS 5 0.0043
85 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
86 ISCHAEMIC CARDIOMYOPATHY 13 0.0042
87 ACUTE LUNG INJURY 5 0.0042
88 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
89 PRODUCT ADMINISTRATION ERROR 83 0.0041
90 NASAL SEPTUM DEVIATION 8 0.0041
91 PRIAPISM 14 0.0041
92 CEREBROVASCULAR ACCIDENT 685 0.0040
93 INJECTION SITE INFLAMMATION 20 0.0040
94 CAROTID ARTERY DISEASE 5 0.0039
95 BRAIN STEM INFARCTION 4 0.0039
96 SLEEP APNOEA SYNDROME 72 0.0038
97 INJECTION SITE CELLULITIS 7 0.0038
98 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
99 DRUG ADMINISTERED AT INAPPROPRIATE SITE 38 0.0036
100 CHRONIC FATIGUE SYNDROME 5 0.0036
101 CARBON DIOXIDE DECREASED 4 0.0035
102 ADMINISTRATION SITE PAIN 4 0.0035
103 RECALLED PRODUCT 6 0.0035
104 RENAL INFARCT 5 0.0035
105 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
106 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 62 0.0034
107 LOSS OF EMPLOYMENT 10 0.0033
108 ANHEDONIA 86 0.0033
109 INTRACARDIAC THROMBUS 10 0.0033
110 TRANSIENT ISCHAEMIC ATTACK 104 0.0031
111 ABDOMINAL OPERATION 4 0.0031
112 ANGINA UNSTABLE 20 0.0031
113 PROSTATOMEGALY 12 0.0031
114 SUSPECTED COUNTERFEIT PRODUCT 12 0.0030
115 INJECTION RELATED REACTION 5 0.0030
116 ACTIVITIES OF DAILY LIVING IMPAIRED 60 0.0030
117 POST-TRAUMATIC STRESS DISORDER 20 0.0030
118 LIBIDO INCREASED 6 0.0030
119 CEREBELLAR INFARCTION 5 0.0030
120 CARBON DIOXIDE INCREASED 4 0.0029
121 SUDDEN CARDIAC DEATH 10 0.0029
122 LACUNAR INFARCTION 7 0.0029
123 PRODUCT PHYSICAL CONSISTENCY ISSUE 16 0.0029
124 INTRACRANIAL PRESSURE INCREASED 16 0.0029
125 HORMONE LEVEL ABNORMAL 14 0.0029
126 CATAPLEXY 4 0.0028
127 RETINAL ARTERY OCCLUSION 7 0.0028
128 HEMIPLEGIA 23 0.0028
129 SUSPECTED PRODUCT QUALITY ISSUE 5 0.0027
130 ERECTILE DYSFUNCTION 70 0.0027
131 BRAIN INJURY 27 0.0027
132 ISCHAEMIC STROKE 48 0.0027
133 NARCOLEPSY 5 0.0026
134 SNORING 10 0.0026
135 PROSTATITIS 8 0.0026
136 HAEMANGIOMA 6 0.0026
137 AORTIC STENOSIS 9 0.0026
138 CARDIAC FAILURE CONGESTIVE 204 0.0025
139 WHEELCHAIR USER 11 0.0025
140 CEREBRAL THROMBOSIS 7 0.0025
141 RENAL HAEMORRHAGE 5 0.0025
142 ACUTE CORONARY SYNDROME 20 0.0024
143 INJECTION SITE ABSCESS 6 0.0024
144 EMBOLISM 20 0.0024
145 CEREBROVASCULAR DISORDER 7 0.0023
146 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
147 THROMBOPHLEBITIS 8 0.0023
148 FAMILY STRESS 7 0.0023
149 IMPAIRED WORK ABILITY 48 0.0022
150 FEAR OF DEATH 5 0.0022
151 SPINAL FUSION SURGERY 9 0.0022
152 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
153 NECK SURGERY 5 0.0021
154 SOMNAMBULISM 14 0.0021
155 DECREASED ACTIVITY 23 0.0021
156 WALKING AID USER 14 0.0021
157 CARDIAC FAILURE ACUTE 14 0.0021
158 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
159 INJECTION SITE NODULE 23 0.0021
160 ADRENAL DISORDER 4 0.0021
161 ARTERIAL THROMBOSIS 4 0.0021
162 SKIN ODOUR ABNORMAL 8 0.0020
163 CARDIOMEGALY 25 0.0020
164 HAIR GROWTH ABNORMAL 14 0.0020
165 ATRIAL FLUTTER 16 0.0020
166 CAROTID ARTERY STENOSIS 7 0.0020
167 LOSS OF LIBIDO 18 0.0020
168 CORONARY ARTERY STENOSIS 10 0.0020
169 SEASONAL ALLERGY 28 0.0020
170 DYSGRAPHIA 13 0.0020
171 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
172 TESTICULAR PAIN 6 0.0019
173 AUTOIMMUNE THYROIDITIS 7 0.0018
174 ANORGASMIA 5 0.0018
175 PRODUCT USE COMPLAINT 29 0.0018
176 CARDIOMYOPATHY 27 0.0018
177 ENDOMETRIAL CANCER 4 0.0018
178 CHOLESTATIC LIVER INJURY 4 0.0018
179 PAPILLOEDEMA 8 0.0018
180 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
181 INJECTION SITE MASS 64 0.0017
182 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
183 HANGOVER 6 0.0017
184 ARTERIOSCLEROSIS 16 0.0017
185 ERECTION INCREASED 7 0.0017
186 METABOLIC ENCEPHALOPATHY 5 0.0017
187 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
188 ARTERIAL OCCLUSIVE DISEASE 13 0.0017
189 OSTEOPENIA 25 0.0016
190 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
191 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
192 FEAR 44 0.0016
193 DERMAL CYST 4 0.0016
194 IMPULSIVE BEHAVIOUR 6 0.0016
195 ONYCHOMYCOSIS 7 0.0016
196 HYPERLIPIDAEMIA 19 0.0016
197 INFUSION SITE PRURITUS 5 0.0016
198 EXERCISE TOLERANCE DECREASED 9 0.0016
199 ACUTE RESPIRATORY FAILURE 30 0.0016
200 PORTAL VEIN THROMBOSIS 5 0.0015
201 PRODUCT SUPPLY ISSUE 11 0.0015
202 CARDIAC DISORDER 144 0.0015
203 LYMPHOCYTE COUNT INCREASED 5 0.0015
204 DECREASED INTEREST 9 0.0015
205 ENERGY INCREASED 9 0.0015
206 VISUAL FIELD DEFECT 11 0.0015
207 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
208 RENAL CYST 12 0.0015
209 CHONDROPATHY 4 0.0015
210 CEREBRAL INFARCTION 36 0.0015
211 SLUGGISHNESS 15 0.0015
212 PERIPHERAL VENOUS DISEASE 6 0.0015
213 INJECTION SITE INDURATION 19 0.0015
214 CARDIOGENIC SHOCK 21 0.0015
215 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
216 SUBCUTANEOUS ABSCESS 7 0.0015
217 CORONARY ARTERY OCCLUSION 20 0.0015
218 CYST 18 0.0014
219 AORTIC ANEURYSM 11 0.0014
220 INJECTION SITE SWELLING 110 0.0014
221 ANGIOPATHY 8 0.0014
222 MUSCLE ATROPHY 18 0.0014
223 HEMIPARESIS 24 0.0014
224 EJACULATION DISORDER 4 0.0014
225 INTERVERTEBRAL DISC DISORDER 6 0.0014
226 BRAIN FOG 22 0.0014
227 PRESCRIBED OVERDOSE 27 0.0014
228 FINE MOTOR SKILL DYSFUNCTION 4 0.0014
229 MONOCYTE COUNT INCREASED 5 0.0014
230 INTENTIONAL DOSE OMISSION 39 0.0014
231 SENSORY LOSS 11 0.0014
232 SEXUAL DYSFUNCTION 16 0.0014
233 ANGINA PECTORIS 39 0.0014
234 PRODUCT DOSE OMISSION ISSUE 399 0.0014
235 SURGERY 78 0.0013
236 CRANIOCEREBRAL INJURY 4 0.0013
237 EMERGENCY CARE 4 0.0013
238 INJECTION SITE WARMTH 27 0.0013
239 PARANASAL SINUS HYPERSECRETION 5 0.0013
240 ANXIETY 369 0.0013
241 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
242 OPTIC ISCHAEMIC NEUROPATHY 5 0.0013
243 PULMONARY THROMBOSIS 14 0.0013
244 BLOOD CREATININE DECREASED 4 0.0013
245 BLINDNESS UNILATERAL 18 0.0013
246 AMNESIA 83 0.0013
247 VENOUS THROMBOSIS 5 0.0013
248 VENTRICULAR FIBRILLATION 14 0.0013
249 VENTRICULAR EXTRASYSTOLES 13 0.0013
250 CELLULITIS 63 0.0012
251 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
252 INJECTION SITE DISCOMFORT 13 0.0012
253 HYPERPROLACTINAEMIA 8 0.0012
254 VITAMIN D DEFICIENCY 12 0.0012
255 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
256 PERIPHERAL ISCHAEMIA 5 0.0012
257 TRIGGER FINGER 5 0.0012
258 GOITRE 5 0.0012
259 PRODUCT PREPARATION ISSUE 8 0.0012
260 SPINAL OPERATION 15 0.0012
261 PRODUCT FORMULATION ISSUE 8 0.0012
262 SINUS DISORDER 24 0.0012
263 FEELING DRUNK 9 0.0012
264 INCORRECT PRODUCT ADMINISTRATION DURATION 26 0.0012
265 ANXIETY DISORDER 4 0.0012
266 BIPOLAR DISORDER 13 0.0012
267 PRODUCT QUALITY ISSUE 162 0.0012
268 ATRIAL FIBRILLATION 116 0.0012
269 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
270 DRUG TOLERANCE 6 0.0012
271 POSTOPERATIVE WOUND INFECTION 8 0.0012
272 DYSLIPIDAEMIA 6 0.0012
273 THERAPEUTIC RESPONSE UNEXPECTED 53 0.0012
274 NIGHT SWEATS 38 0.0012
275 PRODUCT LABEL ISSUE 8 0.0012
276 TONGUE DISCOMFORT 5 0.0012
277 IMPAIRED GASTRIC EMPTYING 16 0.0012
278 ABSCESS LIMB 5 0.0012
279 FACIAL PARALYSIS 10 0.0012
280 NERVE INJURY 13 0.0012
281 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
282 HEART RATE IRREGULAR 26 0.0011
283 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
284 INCORRECT PRODUCT STORAGE 15 0.0011
285 MELANOCYTIC NAEVUS 5 0.0011
286 PRODUCT PHYSICAL ISSUE 23 0.0011
287 SPINAL OSTEOARTHRITIS 10 0.0011
288 EMBOLIC STROKE 4 0.0011
289 TENDON RUPTURE 14 0.0011
290 INFUSION SITE SWELLING 7 0.0011
291 APPARENT DEATH 4 0.0011
292 URINARY TRACT DISORDER 5 0.0011
293 EMOTIONAL DISORDER 34 0.0011
294 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
295 EXOSTOSIS 10 0.0011
296 MAJOR DEPRESSION 8 0.0011
297 CEREBRAL DISORDER 8 0.0011
298 INJURY 76 0.0011
299 DEPRESSION 246 0.0011
300 ADRENAL INSUFFICIENCY 13 0.0011
301 PRODUCT LEAKAGE 6 0.0011
302 INFUSION SITE ERYTHEMA 9 0.0011
303 EMOTIONAL DISTRESS 129 0.0011
304 SQUAMOUS CELL CARCINOMA 10 0.0011
305 INTENTIONAL PRODUCT USE ISSUE 93 0.0011
306 TENDERNESS 11 0.0011
307 CARDIAC VALVE DISEASE 6 0.0010
308 BLOOD MAGNESIUM DECREASED 9 0.0010
309 MUSCLE STRAIN 9 0.0010
310 INJECTION SITE PAIN 317 0.0010
311 METABOLIC DISORDER 6 0.0010
312 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73 0.0010
313 PROSTATIC SPECIFIC ANTIGEN INCREASED 14 0.0010
314 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
315 DISABILITY 20 0.0010
316 FOOT OPERATION 5 0.0010
317 ANGER 34 0.0010
318 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
319 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
320 BONE DENSITY DECREASED 31 0.0010
321 NOCTURIA 12 0.0010
322 POST PROCEDURAL INFECTION 8 0.0010
323 HYPERAESTHESIA 8 0.0010
324 DRUG DIVERSION 6 0.0010
325 PERIPHERAL VASCULAR DISORDER 5 0.0010
326 BURNING SENSATION 68 0.0010
327 PERSONALITY CHANGE 9 0.0010
328 TRISMUS 5 0.0010
329 AORTIC DISSECTION 4 0.0010
330 ACCIDENTAL EXPOSURE 4 0.0010
331 MULTIPLE INJURIES 6 0.0010
332 TASTE DISORDER 19 0.0009
333 VITAMIN D DECREASED 8 0.0009
334 FOOD POISONING 5 0.0009
335 PRODUCT CONTAINER ISSUE 8 0.0009
336 LIMB INJURY 25 0.0009
337 TENDON DISORDER 6 0.0009
338 MENTAL DISORDER 40 0.0009
339 RENAL TUBULAR NECROSIS 9 0.0009
340 DRUG DISPENSING ERROR 14 0.0009
341 DIVERTICULUM INTESTINAL 4 0.0009
342 DYSPHEMIA 4 0.0009
343 FOOD ALLERGY 7 0.0009
344 BURSITIS 11 0.0009
345 HYPERKERATOSIS 5 0.0009
346 APPETITE DISORDER 6 0.0009
347 IMPAIRED QUALITY OF LIFE 13 0.0009
348 PARAESTHESIA ORAL 13 0.0009
349 MALIGNANT MELANOMA 12 0.0009
350 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
351 AFFECTIVE DISORDER 7 0.0009
352 FURUNCLE 7 0.0009
353 ABDOMINAL HERNIA 4 0.0009
354 SCAR 15 0.0009
355 PRODUCT USE ISSUE 164 0.0009
356 TEMPERATURE INTOLERANCE 9 0.0009
357 PRODUCT PRESCRIBING ISSUE 19 0.0009
358 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
359 CORONARY ARTERY BYPASS 5 0.0009
360 EYE OPERATION 4 0.0009
361 NEURALGIA 21 0.0009
362 CONJUNCTIVITIS 16 0.0009
363 HUNGER 12 0.0009
364 BACK DISORDER 14 0.0009
365 WEIGHT FLUCTUATION 9 0.0009
366 PRODUCT LABEL CONFUSION 5 0.0009
367 HICCUPS 7 0.0009
368 COLD SWEAT 15 0.0009
369 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
370 BLOOD PROLACTIN INCREASED 4 0.0008
371 CHRONIC KIDNEY DISEASE 64 0.0008
372 IMMUNE SYSTEM DISORDER 11 0.0008
373 LETHARGY 48 0.0008
374 AFFECT LABILITY 8 0.0008
375 BACK INJURY 9 0.0008
376 RESTLESS LEGS SYNDROME 15 0.0008
377 APATHY 12 0.0008
378 TENSION 5 0.0008
379 DRUG EFFECT DECREASED 44 0.0008
380 SINUS CONGESTION 11 0.0008
381 MUSCLE SPASTICITY 10 0.0008
382 KNEE OPERATION 8 0.0008
383 MENISCUS INJURY 5 0.0008
384 ABDOMINAL TENDERNESS 4 0.0008
385 ANEURYSM 4 0.0008
386 SKIN INFECTION 9 0.0008
387 OSTEOPOROSIS 33 0.0008
388 FLUID INTAKE REDUCED 4 0.0008
389 PAIN 491 0.0008
390 CHEST PAIN 148 0.0008
391 EMPHYSEMA 8 0.0008
392 PHOTOPSIA 5 0.0008
393 MYOCARDIAL ISCHAEMIA 9 0.0008
394 DYSPHORIA 4 0.0008
395 CORONARY ARTERIAL STENT INSERTION 4 0.0008
396 VENTRICULAR TACHYCARDIA 13 0.0008
397 THIRST 14 0.0008
398 EXPIRED PRODUCT ADMINISTERED 26 0.0008
399 PRODUCT SUBSTITUTION ISSUE 45 0.0008
400 ENDOCARDITIS 4 0.0008
401 INITIAL INSOMNIA 8 0.0008
402 CEREBRAL ISCHAEMIA 4 0.0008
403 ATRIOVENTRICULAR BLOCK 6 0.0008
404 INFUSION SITE PAIN 10 0.0008
405 CONCUSSION 6 0.0008
406 OROPHARYNGEAL DISCOMFORT 7 0.0008
407 HYPERSOMNIA 22 0.0008
408 BALANCE DISORDER 66 0.0008
409 CARDIAC ARREST 63 0.0008
410 RETINAL DETACHMENT 7 0.0008
411 DYSURIA 28 0.0008
412 PARANOIA 13 0.0008
413 OBESITY 12 0.0008
414 THINKING ABNORMAL 14 0.0008
415 FEELING ABNORMAL 180 0.0008
416 BLOOD CHOLESTEROL INCREASED 35 0.0008
417 DEFORMITY 7 0.0007
418 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
419 NEPHROLITHIASIS 34 0.0007
420 MUSCLE TIGHTNESS 12 0.0007
421 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
422 PRODUCT DOSE OMISSION 48 0.0007
423 HYPERTENSION 154 0.0007
424 UNDERDOSE 53 0.0007
425 DISTURBANCE IN ATTENTION 39 0.0007
426 DERMATITIS ATOPIC 38 0.0007
427 INJECTION SITE DISCOLOURATION 9 0.0007
428 HIP ARTHROPLASTY 11 0.0007
429 PHARYNGEAL SWELLING 7 0.0007
430 ASTHENIA 269 0.0007
431 BLOOD CALCIUM DECREASED 8 0.0007
432 DELUSION 11 0.0007
433 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
434 DIVERTICULUM 5 0.0007
435 ROTATOR CUFF SYNDROME 9 0.0007
436 MYOCARDITIS 8 0.0007
437 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 125 0.0007
438 ROAD TRAFFIC ACCIDENT 29 0.0007
439 HYSTERECTOMY 6 0.0007
440 SKIN LESION 19 0.0007
441 HYPOTHYROIDISM 22 0.0007
442 FLUID OVERLOAD 10 0.0007
443 MOTOR DYSFUNCTION 7 0.0007
444 GROIN PAIN 6 0.0007
445 FEELING COLD 19 0.0007
446 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
447 ORAL DISORDER 5 0.0007
448 RIB FRACTURE 14 0.0007
449 BLOOD IRON DECREASED 8 0.0007
450 CARDIAC PACEMAKER INSERTION 4 0.0007
451 INJECTION SITE ERYTHEMA 83 0.0007
452 MANIA 11 0.0007
453 ANAL INCONTINENCE 6 0.0007
454 SLEEP DISORDER 47 0.0007
455 GASTROENTERITIS VIRAL 12 0.0007
456 SCRATCH 7 0.0007
457 LOCALISED INFECTION 16 0.0007
458 BODY HEIGHT DECREASED 7 0.0007
459 INSURANCE ISSUE 10 0.0007
460 BRAIN NEOPLASM 6 0.0007
461 POOR QUALITY SLEEP 14 0.0006
462 NERVE COMPRESSION 6 0.0006
463 SPEECH DISORDER 34 0.0006
464 THYROID DISORDER 10 0.0006
465 MUSCULOSKELETAL CHEST PAIN 10 0.0006
466 COORDINATION ABNORMAL 9 0.0006
467 CARPAL TUNNEL SYNDROME 9 0.0006
468 OESOPHAGITIS 7 0.0006
469 HAEMORRHAGIC STROKE 5 0.0006
470 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
471 BLINDNESS 26 0.0006
472 FOOT FRACTURE 12 0.0006
473 DRUG SCREEN POSITIVE 5 0.0006
474 SPUTUM DISCOLOURED 6 0.0006
475 BLOOD POTASSIUM DECREASED 19 0.0006
476 NASAL DISCOMFORT 5 0.0006
477 PARALYSIS 9 0.0006
478 INJECTION SITE IRRITATION 8 0.0006
479 SCIATICA 10 0.0006
480 FATIGUE 487 0.0006
481 SUICIDAL IDEATION 57 0.0006
482 RHINITIS 5 0.0006
483 FRUSTRATION TOLERANCE DECREASED 5 0.0006
484 EXPOSURE VIA SKIN CONTACT 16 0.0006
485 MUSCLE DISORDER 5 0.0006
486 IMPAIRED DRIVING ABILITY 7 0.0006
487 OSTEOARTHRITIS 26 0.0006
488 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
489 MICTURITION URGENCY 7 0.0006
490 DRUG ABUSE 51 0.0006
491 LUNG DISORDER 30 0.0006
492 NEOPLASM 7 0.0006
493 MULTIPLE FRACTURES 10 0.0006
494 TOOTH INFECTION 8 0.0006
495 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
496 PERICARDIAL EFFUSION 14 0.0006
497 DEPRESSED MOOD 32 0.0006
498 PULMONARY MASS 9 0.0006
499 BONE DISORDER 11 0.0006
500 IRRITABILITY 36 0.0006
501 BLOOD UREA INCREASED 10 0.0006
502 PERICARDITIS 10 0.0006
503 INTENTIONAL PRODUCT MISUSE 52 0.0006
504 MEMORY IMPAIRMENT 81 0.0006
505 MIDDLE INSOMNIA 11 0.0006
506 ABNORMAL LOSS OF WEIGHT 4 0.0006
507 MOOD ALTERED 16 0.0006
508 ECCHYMOSIS 4 0.0006
509 DYSSTASIA 17 0.0006
510 BLOOD CREATININE INCREASED 38 0.0006
511 MUSCULOSKELETAL DISCOMFORT 10 0.0006
512 NEUROPATHY PERIPHERAL 55 0.0006
513 COGNITIVE DISORDER 27 0.0006
514 DIABETES MELLITUS 44 0.0006
515 STAPHYLOCOCCAL INFECTION 19 0.0006
516 SINUSITIS 59 0.0006
517 FORMICATION 4 0.0006
518 POST PROCEDURAL COMPLICATION 11 0.0006
519 MUSCULOSKELETAL PAIN 30 0.0006
520 ARRHYTHMIA 27 0.0006
521 KNEE ARTHROPLASTY 12 0.0006
522 BLOOD TEST ABNORMAL 8 0.0006
523 JOINT DISLOCATION 6 0.0006
524 PHARYNGITIS 7 0.0006
525 HAEMORRHOIDS 11 0.0006
526 LACRIMATION INCREASED 17 0.0006
527 JOINT INJURY 12 0.0006
528 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
529 GOUT 10 0.0006
530 DISCOMFORT 34 0.0006
531 BRONCHITIS 41 0.0006
532 BLOOD PRESSURE ABNORMAL 11 0.0006
533 MYALGIA 94 0.0006
534 ANOSMIA 8 0.0006
535 SKIN LACERATION 6 0.0006
536 GAIT DISTURBANCE 105 0.0005
537 HIDRADENITIS 5 0.0005
538 GASTROINTESTINAL PAIN 6 0.0005
539 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
540 TOOTH FRACTURE 6 0.0005
541 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
542 IRON DEFICIENCY ANAEMIA 5 0.0005
543 SKIN ULCER 14 0.0005
544 VIRAL INFECTION 18 0.0005
545 MENTAL STATUS CHANGES 15 0.0005
546 ARTHROPOD BITE 4 0.0005
547 PAIN IN EXTREMITY 159 0.0005
548 MUSCLE SPASMS 99 0.0005
549 BLOOD PRESSURE INCREASED 82 0.0005
550 PRODUCT PREPARATION ERROR 11 0.0005
551 MOOD SWINGS 17 0.0005
552 PERIPHERAL SWELLING 82 0.0005
553 INJECTION SITE URTICARIA 13 0.0005
554 APHASIA 16 0.0005
555 MOBILITY DECREASED 38 0.0005
556 PRODUCT PACKAGING ISSUE 5 0.0005
557 MUSCULOSKELETAL DISORDER 10 0.0005
558 WEIGHT INCREASED 116 0.0005
559 THROAT TIGHTNESS 14 0.0005
560 PSORIATIC ARTHROPATHY 21 0.0005
561 GYNAECOMASTIA 16 0.0005
562 DIZZINESS POSTURAL 5 0.0005
563 PRODUCT STORAGE ERROR 45 0.0005
564 APNOEA 4 0.0005
565 CHOKING 10 0.0005
566 HYPOXIA 18 0.0005
567 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
568 HEAD DISCOMFORT 9 0.0005
569 COVID-19 PNEUMONIA 6 0.0005
570 HYPOAESTHESIA 76 0.0005
571 FEELING HOT 31 0.0005
572 TYPE 2 DIABETES MELLITUS 17 0.0005
573 CHOLECYSTITIS 6 0.0005
574 HALLUCINATION, AUDITORY 8 0.0005
575 UNEVALUABLE EVENT 38 0.0005
576 CARDIO-RESPIRATORY ARREST 21 0.0005
577 MUSCULAR WEAKNESS 57 0.0005
578 DIPLOPIA 13 0.0005
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
580 BLOOD DISORDER 4 0.0005
581 ACUTE KIDNEY INJURY 76 0.0005
582 COVID-19 87 0.0005
583 PANIC ATTACK 18 0.0005
584 FIBROMYALGIA 12 0.0005
585 PRESYNCOPE 12 0.0005
586 BLOOD POTASSIUM INCREASED 8 0.0005
587 FLUID RETENTION 25 0.0005
588 SUBARACHNOID HAEMORRHAGE 5 0.0005
589 INJECTION SITE RASH 15 0.0005
590 SMALL INTESTINAL OBSTRUCTION 6 0.0005
591 ESCHERICHIA INFECTION 4 0.0005
592 CARDIAC FAILURE 39 0.0005
593 ILLNESS 50 0.0005
594 INFECTION 70 0.0005
595 ARTHRITIS 38 0.0005
596 ILEUS 6 0.0005
597 RENAL FAILURE 64 0.0005
598 MIGRAINE 46 0.0005
599 EOSINOPHIL COUNT INCREASED 4 0.0005
600 SECRETION DISCHARGE 6 0.0005
601 TINNITUS 22 0.0005
602 PHOTOPHOBIA 9 0.0005
603 BLOOD SODIUM DECREASED 9 0.0005
604 NASAL CONGESTION 28 0.0005
605 DRUG INEFFECTIVE 625 0.0005
606 HEAD INJURY 15 0.0005
607 BACK PAIN 110 0.0005
608 SKIN HAEMORRHAGE 7 0.0005
609 RENAL DISORDER 22 0.0005
610 SOMNOLENCE 95 0.0005
611 WEIGHT DECREASED 131 0.0005
612 PULMONARY FIBROSIS 9 0.0005
613 DIVERTICULITIS 13 0.0005
614 GLAUCOMA 9 0.0005
615 HAEMATOMA 12 0.0005
616 RESPIRATORY TRACT INFECTION 12 0.0005
617 AGGRESSION 23 0.0005
618 PRODUCT DISPENSING ERROR 10 0.0005
619 DEAFNESS 12 0.0005
620 KIDNEY INFECTION 9 0.0005
621 RASH MACULAR 16 0.0005
622 OSTEONECROSIS 15 0.0005
623 BLOOD CALCIUM INCREASED 4 0.0005
624 PULMONARY CONGESTION 6 0.0005
625 MENTAL IMPAIRMENT 11 0.0005
626 ANKLE FRACTURE 7 0.0005
627 DENTAL CARIES 5 0.0005
628 LYMPHADENOPATHY 16 0.0005
629 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
630 FOOT DEFORMITY 5 0.0005
631 INJECTION SITE REACTION 31 0.0005
632 DYSPNOEA 254 0.0004
633 BASAL CELL CARCINOMA 7 0.0004
634 MALNUTRITION 5 0.0004
635 CEREBRAL HAEMORRHAGE 16 0.0004
636 GASTROINTESTINAL INFECTION 4 0.0004
637 BLOOD BILIRUBIN INCREASED 12 0.0004
638 EYE PAIN 25 0.0004
639 OEDEMA 24 0.0004
640 INCORRECT DOSE ADMINISTERED 101 0.0004
641 OSTEOMYELITIS 8 0.0004
642 MITRAL VALVE INCOMPETENCE 5 0.0004
643 ULCER 7 0.0004
644 ABSCESS 7 0.0004
645 END STAGE RENAL DISEASE 8 0.0004
646 DERMATITIS CONTACT 5 0.0004
647 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
648 ACNE 33 0.0004
649 COUGH 121 0.0004
650 HEPATIC STEATOSIS 8 0.0004
651 NECK PAIN 24 0.0004
652 WITHDRAWAL SYNDROME 18 0.0004
653 INSOMNIA 114 0.0004
654 SPLENOMEGALY 5 0.0004
655 FLANK PAIN 4 0.0004
656 HOT FLUSH 32 0.0004
657 PULMONARY OEDEMA 19 0.0004
658 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
659 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
660 SYNCOPE 42 0.0004
661 HYPERHIDROSIS 54 0.0004
662 SUBDURAL HAEMATOMA 6 0.0004
663 PRODUCTIVE COUGH 20 0.0004
664 ACCIDENT 5 0.0004
665 INCREASED APPETITE 8 0.0004
666 WRIST FRACTURE 5 0.0004
667 CANDIDA INFECTION 7 0.0004
668 HERNIA 8 0.0004
669 HYPOKINESIA 6 0.0004
670 INFLUENZA 46 0.0004
671 AUTOIMMUNE DISORDER 4 0.0004
672 DYSPHONIA 24 0.0004
673 CHEST DISCOMFORT 42 0.0004
674 HYPERSENSITIVITY 76 0.0004
675 POLLAKIURIA 17 0.0004
676 SEIZURE 47 0.0004
677 HYPERCALCAEMIA 5 0.0004
678 MOVEMENT DISORDER 13 0.0004
679 TOOTH DISORDER 9 0.0004
680 ABASIA 10 0.0004
681 ORTHOSTATIC HYPOTENSION 7 0.0004
682 ORAL PAIN 9 0.0004
683 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
684 THERAPY NON-RESPONDER 18 0.0004
685 HEADACHE 251 0.0004
686 DISEASE RECURRENCE 19 0.0004
687 ABNORMAL DREAMS 11 0.0004
688 INTESTINAL OBSTRUCTION 15 0.0004
689 DEHYDRATION 53 0.0004
690 PANCREATITIS 21 0.0004
691 CONFUSIONAL STATE 64 0.0004
692 BRAIN OEDEMA 5 0.0004
693 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
694 RECTAL HAEMORRHAGE 17 0.0004
695 FEEDING DISORDER 8 0.0004
696 PLEURAL EFFUSION 24 0.0004
697 VERTIGO 24 0.0004
698 RENAL IMPAIRMENT 33 0.0004
699 URINARY RETENTION 13 0.0004
700 INJECTION SITE PRURITUS 26 0.0004
701 DYSPEPSIA 38 0.0004
702 DRUG EFFECT INCOMPLETE 14 0.0004
703 PROSTATE CANCER 31 0.0004
704 RHABDOMYOLYSIS 16 0.0004
705 SEDATION 10 0.0004
706 BEDRIDDEN 5 0.0004
707 ANAPHYLACTIC REACTION 21 0.0004
708 ARTHRALGIA 158 0.0004
709 ORAL CANDIDIASIS 5 0.0004
710 HAEMATURIA 13 0.0004
711 SARS-COV-2 TEST POSITIVE 5 0.0004
712 NEEDLE ISSUE 11 0.0004
713 RESPIRATORY TRACT CONGESTION 6 0.0004
714 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
715 EAR INFECTION 10 0.0004
716 EYE HAEMORRHAGE 5 0.0004
717 SWELLING 35 0.0004
718 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
719 CONDITION AGGRAVATED 113 0.0004
720 SKIN CANCER 8 0.0004
721 VISION BLURRED 51 0.0004
722 URINARY INCONTINENCE 11 0.0004
723 RENAL INJURY 11 0.0004
724 FEELING JITTERY 7 0.0004
725 CHOLELITHIASIS 12 0.0004
726 ABDOMINAL DISTENSION 38 0.0004
727 ABDOMINAL DISCOMFORT 61 0.0004
728 APPLICATION SITE PAIN 8 0.0004
729 TREMOR 60 0.0004
730 BLOOD GLUCOSE INCREASED 68 0.0004
731 OFF LABEL USE 316 0.0004
732 ORAL DISCOMFORT 5 0.0004
733 PALPITATIONS 42 0.0004
734 PNEUMONIA 116 0.0004
735 MASS 5 0.0004
736 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
737 FISTULA 4 0.0004
738 PRODUCT COMPLAINT 9 0.0004
739 CHROMATURIA 8 0.0004
740 EYE INFECTION 4 0.0004
741 PAIN IN JAW 10 0.0004
742 NERVOUS SYSTEM DISORDER 11 0.0004
743 LOSS OF CONSCIOUSNESS 45 0.0004
744 INJECTION SITE BRUISING 28 0.0004
745 THERAPY INTERRUPTED 25 0.0003
746 PARAESTHESIA 55 0.0003
747 EYE SWELLING 13 0.0003
748 FALL 116 0.0003
749 EYE IRRITATION 20 0.0003
750 ACCIDENTAL UNDERDOSE 5 0.0003
751 NIGHTMARE 12 0.0003
752 THERAPEUTIC RESPONSE DECREASED 21 0.0003
753 DYSARTHRIA 13 0.0003
754 DYSPNOEA EXERTIONAL 13 0.0003
755 INJECTION SITE HAEMATOMA 5 0.0003
756 HYPERKALAEMIA 12 0.0003
757 AMENORRHOEA 6 0.0003
758 LYMPHOCYTE COUNT DECREASED 6 0.0003
759 TACHYCARDIA 30 0.0003
760 TOOTH LOSS 7 0.0003
761 OCULAR HYPERAEMIA 16 0.0003
762 ATAXIA 4 0.0003
763 NASOPHARYNGITIS 62 0.0003
764 PULMONARY HYPERTENSION 7 0.0003
765 BONE LOSS 5 0.0003
766 HYPOAESTHESIA ORAL 5 0.0003
767 LEUKOCYTOSIS 6 0.0003
768 PNEUMONITIS 9 0.0003
769 CONSTIPATION 72 0.0003
770 SKIN DISORDER 11 0.0003
771 DIZZINESS 164 0.0003
772 INFLUENZA LIKE ILLNESS 27 0.0003
773 DYSPHAGIA 31 0.0003
774 MALAISE 143 0.0003
775 DRUG ADMINISTRATION ERROR 10 0.0003
776 ENCEPHALOPATHY 8 0.0003
777 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
778 BONE PAIN 19 0.0003
779 TENDONITIS 5 0.0003
780 BACTERIAL INFECTION 6 0.0003
781 EPISTAXIS 24 0.0003
782 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
783 BLISTER 18 0.0003
784 PNEUMONIA ASPIRATION 8 0.0003
785 FRACTURE 6 0.0003
786 FLUSHING 32 0.0003
787 VISUAL IMPAIRMENT 39 0.0003
788 AGITATION 23 0.0003
789 HEART RATE INCREASED 31 0.0003
790 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
791 SENSORY DISTURBANCE 5 0.0003
792 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
793 DECREASED APPETITE 72 0.0003
794 DYSGEUSIA 23 0.0003
795 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
796 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
797 PLASMA CELL MYELOMA 12 0.0003
798 RASH 134 0.0003
799 SKIN FISSURES 6 0.0003
800 NERVOUSNESS 16 0.0003
801 HOSPITALISATION 47 0.0003
802 ARTHROPATHY 17 0.0003
803 ECZEMA 16 0.0003
804 LABORATORY TEST ABNORMAL 9 0.0003
805 SKIN DISCOLOURATION 14 0.0003
806 URTICARIA 51 0.0003
807 MUSCLE TWITCHING 7 0.0003
808 WHEEZING 18 0.0003
809 HYPOKALAEMIA 14 0.0003
810 ABNORMAL BEHAVIOUR 12 0.0003
811 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
812 OXYGEN SATURATION DECREASED 17 0.0003
813 HYPOACUSIS 13 0.0003
814 UPPER LIMB FRACTURE 6 0.0003
815 SPINAL FRACTURE 6 0.0003
816 FULL BLOOD COUNT DECREASED 6 0.0003
817 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
818 ILL-DEFINED DISORDER 18 0.0003
819 PRODUCT PRESCRIBING ERROR 7 0.0003
820 TREATMENT NONCOMPLIANCE 16 0.0003
821 CONTUSION 28 0.0003
822 DRUG DOSE OMISSION 48 0.0003
823 ADVERSE DRUG REACTION 26 0.0003
824 PROCEDURAL PAIN 8 0.0003
825 RESPIRATORY FAILURE 21 0.0003
826 SEPSIS 32 0.0003
827 APHONIA 4 0.0003
828 DERMATITIS 6 0.0003
829 MUSCULOSKELETAL STIFFNESS 25 0.0003
830 HEART RATE DECREASED 10 0.0003
831 DRY MOUTH 23 0.0003
832 ASTHMA 32 0.0003
833 DIALYSIS 4 0.0003
834 GALLBLADDER DISORDER 5 0.0003
835 IRRITABLE BOWEL SYNDROME 6 0.0003
836 DIARRHOEA 180 0.0003
837 PRURITUS 107 0.0003
838 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
839 RASH PRURITIC 15 0.0003
840 TOOTHACHE 5 0.0003
841 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
842 LIVER FUNCTION TEST ABNORMAL 8 0.0003
843 GASTROENTERITIS 4 0.0003
844 NAUSEA 216 0.0003
845 THERAPY CESSATION 14 0.0003
846 ASCITES 8 0.0003
847 PSYCHOTIC DISORDER 8 0.0003
848 BLOOD GLUCOSE DECREASED 13 0.0003
849 NO ADVERSE EVENT 49 0.0003
850 FUNGAL INFECTION 9 0.0003
851 PANCREATITIS ACUTE 6 0.0003
852 ERYTHEMA 54 0.0003
853 ABDOMINAL PAIN UPPER 54 0.0003
854 HERPES ZOSTER 15 0.0003
855 DRY EYE 13 0.0003
856 LOWER LIMB FRACTURE 5 0.0003
857 DELIRIUM 9 0.0003
858 FREQUENT BOWEL MOVEMENTS 7 0.0003
859 LIMB DISCOMFORT 8 0.0003
860 HAEMORRHAGE 27 0.0003
861 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
862 EJECTION FRACTION DECREASED 4 0.0003
863 BLOOD PRESSURE DECREASED 17 0.0003
864 OEDEMA PERIPHERAL 31 0.0003
865 SEPTIC SHOCK 11 0.0003
866 CATARACT 15 0.0003
867 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
868 CYSTITIS 8 0.0003
869 HEPATIC ENZYME INCREASED 17 0.0002
870 OROPHARYNGEAL PAIN 23 0.0002
871 CRYING 9 0.0002
872 CHILLS 29 0.0002
873 STOMATITIS 15 0.0002
874 FLATULENCE 14 0.0002
875 EXTRA DOSE ADMINISTERED 10 0.0002
876 ANAEMIA 47 0.0002
877 BODY TEMPERATURE INCREASED 5 0.0002
878 IMPAIRED HEALING 8 0.0002
879 AGEUSIA 6 0.0002
880 HYPOTENSION 48 0.0002
881 ADVERSE EVENT 22 0.0002
882 DRUG RESISTANCE 6 0.0002
883 INFLAMMATION 12 0.0002
884 UNRESPONSIVE TO STIMULI 6 0.0002
885 HEPATIC FAILURE 7 0.0002
886 PYREXIA 80 0.0002
887 HYPONATRAEMIA 13 0.0002
888 VOMITING 108 0.0002
889 URINARY TRACT INFECTION 39 0.0002
890 DISORIENTATION 9 0.0002
891 INJECTION SITE HAEMORRHAGE 18 0.0002
892 SWOLLEN TONGUE 7 0.0002
893 DRUG-INDUCED LIVER INJURY 7 0.0002
894 RASH PAPULAR 5 0.0002
895 THROAT IRRITATION 10 0.0002
896 PAIN OF SKIN 6 0.0002
897 DYSKINESIA 9 0.0002
898 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
899 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
900 RHINORRHOEA 14 0.0002
901 BLOOD GLUCOSE ABNORMAL 4 0.0002
902 ABDOMINAL PAIN 50 0.0002
903 DEMENTIA 6 0.0002
904 WOUND 6 0.0002
905 SKIN EXFOLIATION 18 0.0002
906 EYE DISORDER 7 0.0002
907 HALLUCINATION 16 0.0002
908 VISUAL ACUITY REDUCED 7 0.0002
909 BLOOD URINE PRESENT 4 0.0002
910 GASTRIC ULCER 4 0.0002
911 LIP SWELLING 7 0.0002
912 RED BLOOD CELL COUNT DECREASED 6 0.0002
913 NEOPLASM MALIGNANT 14 0.0002
914 GAIT INABILITY 7 0.0002
915 EYE PRURITUS 7 0.0002
916 BLOOD PRESSURE FLUCTUATION 5 0.0002
917 DRUG PRESCRIBING ERROR 4 0.0002
918 BRADYCARDIA 11 0.0002
919 EAR PAIN 4 0.0002
920 DRY SKIN 27 0.0002
921 GASTROINTESTINAL DISORDER 18 0.0002
922 RESPIRATORY DISORDER 6 0.0002
923 PSORIASIS 26 0.0002
924 JOINT SWELLING 24 0.0002
925 ALOPECIA 39 0.0002
926 MEDICATION ERROR 11 0.0002
927 HYPOPHAGIA 5 0.0002
928 RESTLESSNESS 7 0.0002
929 JOINT STIFFNESS 5 0.0002
930 GASTRITIS 5 0.0002
931 EATING DISORDER 4 0.0002
932 PLATELET COUNT DECREASED 20 0.0002
933 DRUG INTOLERANCE 18 0.0002
934 JAUNDICE 5 0.0002
935 HYPOGLYCAEMIA 9 0.0002
936 RHEUMATOID ARTHRITIS 21 0.0002
937 COLITIS 7 0.0002
938 DEVICE LEAKAGE 8 0.0002
939 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
940 SUICIDE ATTEMPT 11 0.0002
941 HAEMATOCHEZIA 10 0.0002
942 INFUSION RELATED REACTION 12 0.0002
943 FEBRILE NEUTROPENIA 12 0.0002
944 OVERDOSE 39 0.0002
945 HAEMOPTYSIS 5 0.0002
946 COLITIS ULCERATIVE 8 0.0002
947 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
948 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
949 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
950 DEVICE BREAKAGE 7 0.0002
951 NEUTROPHIL COUNT DECREASED 7 0.0002
952 DRUG WITHDRAWAL SYNDROME 15 0.0002
953 THROMBOCYTOPENIA 19 0.0002
954 ACCIDENTAL OVERDOSE 6 0.0002
955 DRUG INTERACTION 26 0.0002
956 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
957 PANCYTOPENIA 9 0.0002
958 DEVICE DISLOCATION 7 0.0002
959 ABDOMINAL PAIN LOWER 4 0.0002
960 LIVER DISORDER 7 0.0002
961 DRUG DEPENDENCE 25 0.0002
962 HIP FRACTURE 5 0.0002
963 ANAPHYLACTIC SHOCK 4 0.0002
964 SWELLING FACE 10 0.0002
965 RASH ERYTHEMATOUS 7 0.0001
966 MULTIPLE SCLEROSIS 7 0.0001
967 LUNG NEOPLASM MALIGNANT 6 0.0001
968 CONVULSION 8 0.0001
969 HYPERGLYCAEMIA 5 0.0001
970 DEATH 116 0.0001
971 DEVICE ISSUE 12 0.0001
972 FEMUR FRACTURE 4 0.0001
973 DISEASE PROGRESSION 14 0.0001
974 RENAL FAILURE ACUTE 5 0.0001
975 NEUTROPENIA 16 0.0001
976 HAEMOGLOBIN DECREASED 12 0.0001
977 GASTRIC DISORDER 4 0.0001
978 DEVICE USE ERROR 4 0.0001
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
980 COMA 5 0.0001
981 BLADDER CANCER 6 0.0001
982 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
983 DEVICE MALFUNCTION 7 0.0001
984 TREATMENT FAILURE 8 0.0001
985 INTENTIONAL OVERDOSE 6 0.0001
986 DEPENDENCE 5 0.0001
987 COMPLETED SUICIDE 7 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
989 DRUG DOSE OMISSION BY DEVICE 6 0.0001
990 BREAST CANCER 7 0.0001
991 SKIN BURNING SENSATION 5 0.0001
992 DEVICE DIFFICULT TO USE 4 0.0001
993 TOXICITY TO VARIOUS AGENTS 7 0.0000